Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000504 |
---|---|
Receipt number | R000000609 |
Scientific Title | The safety and efficacy trial of sequential administration with AP (Doxorubicin/Paclitaxel) followed by weekly Paclitaxel as preoperative chemotherapy for breast cancer: SBCCSG-07 |
Date of disclosure of the study information | 2006/10/30 |
Last modified on | 2018/12/18 19:50:29 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2006/10/27 13:26:10 | ||
2 | Update | 2007/05/02 07:51:37 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
3 | Update | 2007/05/02 07:56:51 | Address Address TEL Organization Organization Address Address TEL |
|
4 | Update | 2008/04/28 08:35:00 | Recruitment status Publication of results |
|
5 | Update | 2017/11/30 18:02:04 | UMIN ID1 |
|
6 | Update | 2018/12/18 19:50:29 | Recruitment status Date of protocol fixation Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |